注射用绒促性素中纯度测定方法的研究
Study on the purity determination of chorionic gonadotrophin for injection
分类号:
出版年·卷·期(页码):2012,32 (2):0-0
DOI:
10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------
目的: 建立了分子排阻法测定注射用绒促性素中纯度的方法,并在2010年度国家药品质量评价性抽验工作中,按照所建方法对国产注射用绒促性素进行了测定和评价。 方法: 采用两根TSK G3000SWXL凝胶色谱柱(7.8 mm×300 mm,5 μm)串联,预柱为TSK SWXL(6.0 mm×40 mm,5 μm),以0.05 mol·L-1磷酸二氢钠缓冲液(pH 7.0)-乙腈(80∶20)为流动相,流速0.6 mL·min-1,检测波长214 nm,面积归一化法定量。 结果: 卵泡刺激素(FSH)和绒促性素(HCG)分离完全,各辅料均无干扰,绒促性素的效价比活和纯度呈正相关。目前法定检验标准中无此检查项,76批样品全部合格,没有发现问题;若按本法进行纯度检查,则样品的不合格率显著增加。 结论: 本法具有较高的选择性,结果稳定、准确可靠,通过测定绒促性素的纯度可达到监控制剂生产过程中所使用原料的效价比活的目的。在此次专项抽验中发现现行标准存在缺陷,仍有待进一步提高,可采用专属性较强的仪器分析法如分子排阻法检查该品种的纯度或进行鉴别。
-----英文摘要:---------------------------------------------------------------------------------------
Objective: To establish a Size Exclusion Chromatography method for the purity determination of Chorionic gonadotrophin for Injection.The method was applied for the domestic Chorionic Gonadotrophin for Injection of national drug evaluation in 2010. Methods: Two TSK G3000SWXL gel columns (7.8 mm×300 mm,5 μm) series connected,TSK SWXL (6.0 mm×40 mm,5 μm) as guard column.The mobile phase consisted of 0.05 mol·L-1 NaH2PO4 (pH 7.0) - acetonitrile(80∶20) at the flow rate of 0.6 mL·min-1 with the detection wavelength of 214 nm.The drug purity content was quantified by peak area normalization method. Results: FSH and HCG were separated completely,with no interference from excipients.The specific activity of HCG showed positive correlation with its purity.This test is not included in the official acceptance standard currently.In the 76 tested batches,many of them were found disqualified with this purity test while totally accordance with the official standard.Inclusion:The method showed high selectivity,reliability,and sensitivity.HCG purity test can be applied for specific activity control of materials in production.Further improvement are needed for the current standard.
-----参考文献:---------------------------------------------------------------------------------------
[1] WANG Xiu-ping(王秀萍),JIAO Lin (焦琳),GUO Hong-yan(郭红燕).Advances in clinical application of human chorionic gonadotropin (人绒毛膜促性腺激素的临床应用进展).Pharm Care Res (药学服务与研究),2010,10(3):185
[2] ChP(中国药典).2005.Vol.Ⅱ(二部):455
[3] ChP(中国药典).2010.Vol.Ⅱ(二部):622
[4] BP.2010.492
[5] USP.33.2523
[6] JP.2006.708
[7] Almeida BE,Oliveira JE,Carvalho CM,et al.Analysis of human luteinizing hormone and human chorionic gonadotropin preparations of different origins by reversed-phase high-performance liquid chromatography.J Pharm Biomed Anal,2010,53:90
[8] ZHAO Xiao-dong(赵晓冬),FU Rong(傅蓉),WANG Jian (王坚),et al.Determination of high molecular mass impurities in cefuroxime sodium and sulbactam sodium for injection by molecular exclusion chromatography (分子排阻色谱法测定注射用头孢呋辛钠舒巴坦钠中的高分子杂质).Chin J Pharm Anal (药物分析杂志),2010,30(1):95
[9] WANG Bing(汪冰),XIAO Xin-yue (肖新月),CHENG Xian-long(程显隆),et al.Study on relative molecular mass distribution of protein and peptide in donkey - hide glue by gel exclusion chromatography (凝胶排阻色谱法研究阿胶中蛋白质及多肽相对分子质量分布规律).Chin J Pharm Anal (药物分析杂志),2009,29(11):1886
欢迎阅读《药物分析杂志》!您是该文第 1276位读者!